-TheGoan.net As had been anticipated, on October 18, the Cabinet Committee of Economic Affairs chaired by Prime Minister Narendra Modi decided to decontrol the prices of diesel, the most widely-used petroleum product in the country. Riding on an unexpected fall in world prices of crude oil, the government was able to simultaneously announce a sharp fall in consumer prices of diesel by Rs 3.37 per litre (in Delhi). But the decision...
More »SEARCH RESULT
Total Matching Records found : 4031
Govt allows field trials for GM mustard, brinjal -Chetan Chauhan
-The Hindustan Times The environment ministry has allowed field trials of two varieties of genetically modified (GM) brinjal and mustard, almost 18 months after the previous government ordered a freeze on such tests. In a reply to an RTI query early October, the ministry said on August 21, it permitted the Delhi University to hold trials for a mustard variety and Maharashtra-based Bejo Seeds Pvt Ltd to test Bt brinjal. The decision does...
More »Reforming the health care sector -Ian D Spatz
-The Hindu Obamacare and other such examples make a compelling case for seeking the right combination of roles for the public and private sector in health reform in India Nail or screw? Which is best to join pieces of wood? In carpentry, the answer is that each offers benefits depending on the application. With health care reform, the choice of public or private sector financing, delivery and regulation is subject to a...
More »Supreme Court refuses to hear challenge on NPPA decision -Apoorva
-Livemint The petition challenged NPPA's decision of withdrawing its internal guideline to set prices of non-essential drugs New Delhi: The Supreme Court on Monday refused to entertain a petition challenging a decision by the country's drug price regulator to withdraw its internal guideline to set prices of non-essential drugs. Earlier this year, the National Pharmaceutical Pricing Authority (NPPA) issued a guideline empowering itself to cap the prices of 108 non-essential drugs, attracting...
More »Pvt sector deserts war on TB, funding down 33% since 2011 -Subodh Varma
-The Times of India Even as tuberculosis (TB) continues to haunt the world, a new study has revealed that funding for research and development of new drugs to fight the disease is floundering. Private sector funding has declined by more than a third since 2011 as pharma Companies are closing their TB research programmes. Pfizer shut down its TB drug discovery programme in 2012, AstraZeneca in 2013 and Novartis in 2014. Meanwhile,...
More »
